Compare VIRT & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIRT | COO |
|---|---|---|
| Founded | 2008 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 16.1B |
| IPO Year | 2015 | N/A |
| Metric | VIRT | COO |
|---|---|---|
| Price | $33.68 | $81.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 11 |
| Target Price | $41.43 | ★ $88.55 |
| AVG Volume (30 Days) | 761.0K | ★ 3.8M |
| Earning Date | 01-28-2026 | 12-04-2025 |
| Dividend Yield | ★ 2.85% | N/A |
| EPS Growth | ★ 132.69 | N/A |
| EPS | ★ 4.62 | 1.87 |
| Revenue | $2,694,104,000.00 | ★ $4,092,400,000.00 |
| Revenue This Year | N/A | $6.66 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | ★ $7.30 | $43.89 |
| Revenue Growth | ★ 41.05 | 5.06 |
| 52 Week Low | $31.89 | $61.78 |
| 52 Week High | $45.77 | $100.24 |
| Indicator | VIRT | COO |
|---|---|---|
| Relative Strength Index (RSI) | 40.56 | 67.58 |
| Support Level | $34.81 | $77.64 |
| Resistance Level | $36.25 | $89.83 |
| Average True Range (ATR) | 0.86 | 2.41 |
| MACD | -0.09 | 0.45 |
| Stochastic Oscillator | 9.19 | 47.46 |
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.